Biotech News Releases

1 News Releases · Displaying 1 - 1

Skila Expert Featured in PharmaVoice Article on Safe Rx Act
Susan Dorfman, Vice President of Global Marketing from Skila, A Sela2 Company, conveys her opinions regarding the ramifications and implications of the Safe Rx Act in the article entitled “Licensed to Sell”, which appears in the April 2008 issue of PharmaVoice. - April 12, 2008